6505--Adalimumab Pen/Syringe Kits
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36E79723R0038
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation seeks proposals for the supply of adalimumab pen and syringe kits to be distributed through the Department of Veterans Affairs Pharmaceutical Prime Vendor program. The Department of Veterans Affairs National Acquisition Center is soliciting these products for a one year base period and four one year option periods. Offerors must propose pricing for the kits in 40mg doses for the base year through all option periods, and proposed pricing must include a 0.5% cost recovery fee. Manufacturing facilities must be FDA registered. Proposals are due by November 16, 2023 at 2:30pm Central Time. The contract will be awarded to responsible contractors who meet the requirements for each proposed product group.
There is no set-aside designation. The primary NAICS code is 325412, Pharmaceutical Preparation Manufacturing, and the primary PSC code is 6505, Adalimumab. Estimated annual quantities are provided for VA, IHS, and BOP facilities. An amendment to the solicitation extended the proposal due date from November 10, 2023 to November 16, 2023, maintaining all other terms. Packaging and barcoding requirements are identified.
Notice text
2 versions
Update #2 · Latest ·
Extend due date to 11/16/2023.
Update #1 ·
N/A
Files
| File | Type | Posted |
|---|---|---|
| 36E79723R0038 0001.docx | DOCX document | |
| 36E79723R0038.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Adalimumab Pen/Syringe Kits | Award Notice | |
| This notice | Solicitation | |
| 6505--Adalimumab Pen/Syringe Kits | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity